| | | Hello Traders,
This $1.25 medical diagnostics company catches the attention of two Wall Street analysts predicting 833% upside.
One analyst report found here states a 12 mo. target price of $11.20 as the second covid-19 wave hits our country.
This tiny little-known stock manufactures COVID-19 rapid tests world-wide, and our NAVY was one of the first buyers in February.
You Can Access The Analyst Report For Free Right Here
The company drastically raised its revenue outlook for this quarter on the basis of strong demand for its COVID-19 testing solutions.
James Michaels
Researcher, Empire Trading Group
P.S. Early investors could make an absolute fortune by acting now. Go here now to see the detailed analyst research report!
DailyMarketAlerts does NOT specifically endorse this product nor is it responsible for the content of this paid communication. Furthermore, we make no guarantee or warranty about what is communicated above.
|
|
If you no longer wish to receive our emails, click the link below:
UnsubscribeDailyMarketAlerts 315 Ridgedale Avenue #556 East Hanover, New Jersey 07936 United States
No comments:
Post a Comment